Adenosine primes resting stage dendritic cells before their activation
Authors:
- 1 March 2009
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 380 (4) , 748-751
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- A2A receptors in inflammation and injury: lessons learned from transgenic animalsJournal of Leukocyte Biology, 2007
- Adenosine Deamination Sustains Dendritic Cell Activation in InflammationThe Journal of Immunology, 2007
- A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T CellsThe Journal of Immunology, 2005
- Animal models for the study of adenosine receptor functionJournal of Cellular Physiology, 2004
- PhysiologicalControl ofImmuneResponse andInflammatoryTissueDamage byHypoxia-InducibleFactors andAdenosineA2AReceptorsAnnual Review of Immunology, 2004
- Adenosine: an endogenous regulator of innate immunityTrends in Immunology, 2004
- The structure and function of CD26 in the T‐cell immune responseImmunological Reviews, 1998
- THE ANTI-INFLAMMATORY POTENTIAL OF ADENOSINE IN ISCHEMIA-REPERFUSION INJURYShock, 1997
- Role of A2a Extracellular Adenosine Receptor-Mediated Signaling in Adenosine-Mediated Inhibition of T-Cell Activation and ExpansionBlood, 1997